Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

The emergence of novel SARS-CoV-2 variants led to the recommendation of booster vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster vaccination induces high antibody levels, but how heterologous boosters affect other functional aspects of the immune response rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Geers, Daryl, Sablerolles, Roos S.G., van Baarle, Debbie, Kootstra, Neeltje A., Rietdijk, Wim J.R., Schmitz, Katharina S., Gommers, Lennert, Bogers, Susanne, Nieuwkoop, Nella J., van Dijk, Laura L.A., van Haren, Eva, Lafeber, Melvin, Dalm, Virgil A.S.H., Goorhuis, Abraham, Postma, Douwe F., Visser, Leo G., Huckriede, Anke L.W., Sette, Alessandro, Grifoni, Alba, de Swart, Rik L., Koopmans, Marion P.G., van der Kuy, P. Hugo M., GeurtsvanKessel, Corine H., de Vries, Rory D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726653/
https://www.ncbi.nlm.nih.gov/pubmed/36507223
http://dx.doi.org/10.1016/j.isci.2022.105753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726653/
https://www.ncbi.nlm.nih.gov/pubmed/36507223
http://dx.doi.org/10.1016/j.isci.2022.105753

Ejemplares similares